CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Boils, carbuncles, folliculitis, paronychia and staphylococcal whitlow - Management
Are there any other key issues I should be aware of before prescribing?
Flucloxacillin
- Flucloxacillin has been associated with an increased risk of hepatic disorders, namely hepatitis and cholestatic jaundice.
- The Committee on Safety of Medicines (CSM) advises that hepatic reactions may occur up to 2 months after treatment with flucloxacillin has stopped. Risk factors include treatment for more than 14 days and increasing age. The dose and route of administration do not appear to affect this risk.
Erythromycin and clarithromycin
- Erythromycin commonly causes gastrointestinal adverse effects, especially at higher doses. If this is known to occur, consider prescribing clarithromycin instead.
- Erythromycin and clarithromycin can increase the levels of certain other drugs (e.g. theophylline, carbamazepine) and can potentiate the effects of warfarin.
- They can also prolong the QT interval. If possible, avoid giving erythromycin or clarithromycin if the person is already taking a drug that can potentially prolong the QT interval (e.g. antiarrhythmics, antipsychotics, tricyclic antidepressants) or if the person has hypokalaemia, which also increases the risk of QT prolongation.
- If they are taken with a statin, there is an increased risk of myopathy.
Ibuprofen
- As with other nonsteroidal anti-inflammatory drugs, ibuprofen may worsen or precipitate gastrointestinal haemorrhage, asthma, hypertension, renal impairment, or cardiac failure. Avoid ibuprofen if there is a history of peptic ulcers, and in pregnant women.
© NHS Institute for Innovation and Improvement